Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Hao Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0000-9468-2759; OpenAlex author ID A5111287762. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. A Controllability Reinforcement Learning Method for Pancreatic Cancer Biomarker Identification. Last author DOI 10.1109/tnb.2024.3441689↗
  2. The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in Pancreatic Cancer Cells First author DOI 10.21203/rs.3.rs-1374979/v1↗
  3. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Co-author DOI 10.1016/j.bbrc.2018.05.024↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan Wang · 1 shared paper, 2024 · strength 0.22
  2. Wenjing Sun · 1 shared paper, 2022 · strength 0.17
  3. Jianjun Gao · 1 shared paper, 2022 · strength 0.17
  4. Dongsheng Wang · 1 shared paper, 2022 · strength 0.17
  5. Xiangyu Zhong · 1 shared paper, 2022 · strength 0.17
  6. Lining Huang · 1 shared paper, 2018 · strength 0.09
  7. Yunfu Cui · 1 shared paper, 2018 · strength 0.09
  8. Yufu Wang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.